PBM rebates’ impact at the Rx counter
One of the great paradoxes in medicine today is the reality that drug prices are rising at the lowest level…
April 27, 2018 by Dan Leonard Issue 04-23-2018, Opinion
One of the great paradoxes in medicine today is the reality that drug prices are rising at the lowest level…
March 19, 2018 by Jeffrey Woldt and Chain Drug Review 2018, Issue 03-19-2018, Issues, Leading Headlines, Opinion
An understanding of the value created by the National Association of Chain Drug Stores’ annual RxImpact Day — for the…
March 19, 2018 by Jen Johnston and Chain Drug Review 2018, Issue 03-19-2018, Issues, Opinion
New product launches have a notoriously high failure rate. In fact, Nielsen once pegged the failure rate of new consumer…
March 19, 2018 by Hemal Nagarsheth and Chain Drug Review 2018, Issue 03-19-2018, Issues, Opinion
We are now more than 20 years into the e-commerce era of retail. As many brick-and-mortar retail sectors have found…
February 26, 2018 by Jeffrey Woldt and Chain Drug Review 2018, Issue 02-26-2018, Issues, Opinion
The National Association of Chain Drug Stores is gearing up for three big events in the coming months, each of…
February 26, 2018 by Natalie Kish, Maulik Bhagat and Chain Drug Review 2018, Issue 02-26-2018, Issues, Leading Headlines, Opinion
CVS Health’s announcement that it would acquire Aetna for $69 billion is only one of recent health care services deals…
February 26, 2018 by John Zealley and Chain Drug Review 2018, Issue 02-26-2018, Issues, Opinion
Not so long ago large multinational consumer packaged goods companies competed against one another by seeking out new markets to…
February 12, 2018 by Jeffrey Woldt and Chain Drug Review 2018, Issue 02-12-2018, Issues, Opinion
The announcement by CVS Pharmacy president Helena Foulkes at last month’s National Retail Federation Big Show that the retailer will…